Page last updated: 2024-09-04

docetaxel anhydrous and fluorocholine

docetaxel anhydrous has been researched along with fluorocholine in 2 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (fluorocholine)	Trials (fluorocholine)	Recent Studies (post-2010) (fluorocholine)
12,110	3,216	6,920	302	23	246

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, I; Kwee, S; Loo, L; Song, MA; Tiirikainen, M	1
Burgio, SL; Caroli, P; Casadio, V; Conteduca, V; De Giorgi, U; Gurioli, G; Lolli, C; Matteucci, F; Menna, C; Paganelli, G; Salvi, S; Scarpi, E; Schepisi, G; Testoni, S	1

Other Studies

2 other study(ies) available for docetaxel anhydrous and fluorocholine

Article	Year
Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer. Clinical and translational science, 2012, Volume: 5, Issue:1 Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choline; DNA Methylation; DNA, Neoplasm; Docetaxel; Electrophoresis, Microchip; Genetic Markers; Glutathione S-Transferase pi; Hawaii; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Receptors, Retinoic Acid; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging	2012
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer. Scientific reports, 2017, Nov-14, Volume: 7, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Chlorine; Choline; Docetaxel; Gene Dosage; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction	2017

Article

Year

Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.

Clinical and translational science, 2012, Volume: 5, Issue:1

Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choline; DNA Methylation; DNA, Neoplasm; Docetaxel; Electrophoresis, Microchip; Genetic Markers; Glutathione S-Transferase pi; Hawaii; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Receptors, Retinoic Acid; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging

2012

Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.

Scientific reports, 2017, Nov-14, Volume: 7, Issue:1

Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Chlorine; Choline; Docetaxel; Gene Dosage; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction

2017